Evidence map›Paper›PMID 34405021›Full record

ArticleJournal of Cancer2021

Comprehensive analysis of Transcription Factors identified novel prognostic biomarker in human bladder cancer.

Yihao Liao, Xuanxuan Zou, Keke Wang, Youzhi Wang, Miaomiao Wang, Tao Guo, Boqiang Zhong, Ning Jiang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yihao LiaoTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Xuanxuan ZouCollege of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.
Keke WangTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Youzhi WangTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Miaomiao WangTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Tao GuoTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Boqiang ZhongTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Ning JiangTianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Tianjin Medical University · CNSecond Hospital of Tianjin Medical University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkerBladder cancerPrognosisTranscription FactorsWGCNA

Identifiers

PMID34405021
PMCPMC8364643
OpenAlexW3191308004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.